Press "Enter" to skip to content

Dr Reddy’s launches oral suspension drug in the US market

Quoting IMS Health data, the company said the Renvela brand and generic had US sales of approximately USD 101 million for the most recent 12 months ending in October 2018.

Original source: https://health.economictimes.indiatimes.com/news/pharma/dr-reddys-launches-oral-suspension-drug-in-the-us-market/67271036?utm_source=RSS&utm_medium=ETRSS

Also Read:   Ranitidine under lens after carcinogen alert